Sanjeev Sharma, MD
Radiation Oncology · Huntington, WVNPI 1164409884
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Novartis at 26.3% of the total. 2025 is the largest year on record at $313, 3.9 times the $81 reported in 2019.
Across 41 payments — averaging $24.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$264
- Elekta, Inc.$122
- GE HealthCare$96
- Boston Scientific$92
- Siemens Medical Solutions USA, Inc.$65
- Telix Pharmaceuticals$63
- plus $299 from 10 others
What the payments were for
- Food & beverage$98498%
- Education$162%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 15 | $264 |
| Elekta, Inc. | 2 | $122 |
| GE HealthCare | 1 | $96 |
| Boston Scientific | 3 | $92 |
| Siemens Medical Solutions USA, Inc. | 3 | $65 |
| Telix Pharmaceuticals | 3 | $63 |
| Reflexion Medical, Inc. | 2 | $63 |
| Bayer | 3 | $59 |
| Pfizer | 2 | $42 |
| AbbVie | 1 | $34 |
| Progenics Pharmaceuticals, Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Brainlab, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Accuray Incorporated | 1 | $16 |
| Medtronic | 1 | $15 |
How this compares
$1,001 in reported general payments places this provider in the 70th percentile of 29 radiation oncology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pilocarpine Hcl | 25 | $2,775 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $777 |
| Dexamethasone | 36 | $719 |
| Tamsulosin Hcl | 39 | $521 |
| Lidocaine Hcl ViscousLidocaine Hcl | 14 | $308 |
| Finasteride | 14 | $268 |
| Ondansetron OdtOndansetron | 12 | $198 |
| Silver Sulfadiazine | 18 | $178 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $129 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $87 |
| Methylprednisolone | 14 | $73 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Huntington
- John VarlottoHuntington$120K
- Paul AdedoyinHuntington$3K
- Grace DixonHuntington$145
- Mary ContiHuntington$108
- Sophia Edwards-BennettHuntington$47
- Gregory MerrickWheeling$21K
- David ShimmBeckley$5K
- Benjamin YanMorgantown$2K
- Michael GallowayElkins$1K
- Jondavid PollockWheeling$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.